Company overview
Logical Biological supplies high-quality human biological materials including serum, plasma, tissues, PBMCs, swabs, and cells to support in vitro diagnostics (IVD) control manufacturing, diagnostics, and therapeutics R&D. The company offers customizable biospecimens, bulk disease state plasma, and engineered materials through partnerships, backed by extensive development and manufacturing capabilities. Headquartered in the UK with a global network of 45 clinical collection sites, it ensures sustainable supply to international customers.
Biological raw materials- Logical Biological is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include biological raw materials, human plasma, biospecimens, ivd controls, disease state plasma, pbmcs.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://logicalbiological.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- biological raw materials, human plasma, biospecimens, ivd controls, disease state plasma, pbmcs, clinical collection sites
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What biological materials does Logical Biological supply?
- They provide serum, plasma, swabs, tissues, PBMCs, cells, whole blood, urine, CSF, stools, saliva, sputum, and bulk disease state materials for IVD and research applications.
- What are Logical Biological's certifications and quality standards?
- Logical Biological holds ISO 9001:2015 certification and received a King’s Award for Enterprise in 2024 for international trade excellence.
- Where does Logical Biological source materials from?
- Headquartered in the UK at Discovery Park, Sandwich, Kent, they partner with a global network of 45 clinical collection sites for sustainable, high-quality raw materials.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
